|Tested species reactivity||Virus|
|Published species reactivity||Human, Not Applicable|
|Host / Isotype||Mouse / IgG1, lambda|
|Immunogen||Purified HbsAg, subtype ayw3|
|Storage buffer||tissue culture supernatant|
|Contains||0.09% sodium azide|
|Storage Conditions||4° C|
|Tested Applications||Dilution *|
|Immunohistochemistry (Paraffin) (IHC (P))||1:25-1:50|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
MA5-13059 targets Hepatitis B Virus Surface Antigen in IHC (P) applications and shows reactivity with Human samples.
The MA5-13059 immunogen is purified HbsAg, subtype ayw3.
Ab-1 recognizes a protein in the outer surface coat of hepatitis B virus.
Hepatitis B virus causes type B hepatitis and it belongs to hepadnavirus family. It is spherical in shape with a diameter of 42 nm. It contains a 27 nm partially double stranded DNA core enclosed within a lipoprotein coat. The antigenic activity of the nucleocapsid core is designated as hepatitis B core antigen. The antigens in the outer surface are called as hepatitis B virus surface antigens. Core antigens are localized within the nuclei whereas the surface antigens are present in the cytoplasm of the infected cells. Antibodies to surface antigens appear in circulation at an early stage of infection whereas the antibodies to the core antigens are detected after several weeks.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Biological characteristics of the A1762T/G1764A mutant strain of hepatitis B virus in vivo.
MA5-13059 was used in immunohistochemistry - paraffin section to characterize the biology of a mutant strain of hepatitis B virus in vivo called A1762T/G1764A
|Leng XH,Chen EQ,Du LY,Bai L,Gong DY,Cheng X,Huang FJ,Tang H||Molecular medicine reports (12:5141)||2015|
Fibrinogen storage disease without hypofibrinogenemia associated with estrogen therapy.
MA5-13059 was used in immunohistochemistry to report on a case of fibrinogen storage disease without hypofibrinogenemia associated with estrogen therapy
|Simsek Z,Ekinci O,Cindoruk M,Karakan T,Degertekin B,Akyol G,Unal S||BMC gastroenterology (5:null)||2005|